These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9172701)

  • 1. [Comparative study of three antineoplastic alkylating agents on DNA].
    Babaian IuS; Khudaverdian NV; Karapetian LG; Kazarian RS; Sogomonian LR
    Biofizika; 1997; 42(2):542-3. PubMed ID: 9172701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of imidazen in combination with RNA on the structure of DNA from sarcoma 45].
    Babaian IuS; Khudaverdian NV; Sngrian AE; Garibian DV; Danielian IS
    Biofizika; 1997; 42(1):125-8. PubMed ID: 9181785
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in the structure of DNA induced by sarcolysine in vivo and in vitro].
    Babaian IuC; Garibian DV; Danielian IS; Aslanian VM; Garibdzhanian BT
    Vopr Med Khim; 1984; 30(5):92-5. PubMed ID: 6528526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interaction of sarcolysine with the DNA from tumorous and homologous normal tissues].
    Iamshanov VA
    Vopr Onkol; 1974; 20(3):69-73. PubMed ID: 4373914
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental use of low-energy infrared laser radiation to stimulate antitumor effect of cyclophosphane].
    Sheĭko EA; Shikhliarova AI; Kurkina TA
    Vopr Onkol; 2004; 50(5):576-9. PubMed ID: 15715100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modification of DNA-specific methylation in tissues of healthy and tumor bearing (sarcoma 45) rats under the effect of an active alkylating cancerolytic agent].
    Garibian V; Stephanian GM; Danielian IS; Babaian KuC ; Arutiunian SG
    Biokhimiia; 1980 Nov; 45(11):2028-35. PubMed ID: 6940625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on Crocker sarcoma under the effect of alkylating agents. II. Cytochemistry of nucleic acids and proteins in malignant cells of sarcoma 180 after treatment with the antitumour drug DL-sarcolysine.
    el-Fiky SM; Taha Y
    Acta Histochem; 1969; 34(2):246-56. PubMed ID: 4986951
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduced liver uptake of arterially infused melphalan during retrograde rat liver perfusion with unaffected liver tumor uptake.
    Rothbarth J; Sparidans RW; Beijnen JH; Schultze-Kool LJ; Putter H; van de Velde CJ; Mulder GJ
    J Pharmacol Exp Ther; 2002 Nov; 303(2):736-40. PubMed ID: 12388659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of melphalan-DNA adducts in colon cancer cells in vitro and human colorectal liver tumours in vivo.
    Rothbarth J; Koevoets C; Tollenaar RA; Tilby MJ; van de Velde CJ; Mulder GJ; Kuppen PJ
    Biochem Pharmacol; 2004 May; 67(9):1771-8. PubMed ID: 15081876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies.
    Brunstein F; Hoving S; Seynhaeve AL; van Tiel ST; Guetens G; de Bruijn EA; Eggermont AM; ten Hagen TL
    J Natl Cancer Inst; 2004 Nov; 96(21):1603-10. PubMed ID: 15523089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of phosphemide in combination with dexamethasone on DNA structure in sarcoma 45].
    Babaian IuS; Aslanian LL; Ananian GV; Garibian DV
    Biofizika; 1985; 30(3):414-7. PubMed ID: 4027269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma.
    Boccadoro M; Palumbo A; Bringhen S; Merletti F; Ciccone G; Richiardi L; Rus C; Bertola A; Giaccone L; Omedè P; Musto P
    Haematologica; 2002 Aug; 87(8):846-50. PubMed ID: 12161361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of sarcolysine on H3-thymidine incorporation in DNA of cells of surviving sections of sarcoma 298].
    Merkulov MF; Shelaputina ZF
    Farmakol Toksikol; 1970; 33(3):361-6. PubMed ID: 5453036
    [No Abstract]   [Full Text] [Related]  

  • 14. Topoisomerase II beta levels are a determinant of melphalan-induced DNA crosslinks and sensitivity to cell death.
    Emmons M; Boulware D; Sullivan DM; Hazlehurst LA
    Biochem Pharmacol; 2006 Jun; 72(1):11-8. PubMed ID: 16678798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersensitivity to DNA cross-linking agents associated with up-regulation of glucose-regulated stress protein GRP78.
    Chatterjee S; Hirota H; Belfi CA; Berger SJ; Berger NA
    Cancer Res; 1997 Nov; 57(22):5112-6. PubMed ID: 9371511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
    Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M
    Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Features of the interaction of antitumor mitoxantrone compounds with sarcoma 45 tumor DNA].
    Babaian IuS
    Biofizika; 1991; 36(1):35-8. PubMed ID: 1854828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitro.
    Papadopoulou MV; Ji M; Khan SH; Bloomer WD
    Oncol Res; 1999; 11(8):345-57. PubMed ID: 10803738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The specificity of inhibition of tumor cell viability by DNA.
    Glick JL
    Cancer Res; 1967 Dec; 27(12):2338-41. PubMed ID: 4866763
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of monochromatic red lighting potentiating antitumor action of cyclophosphamide injected with autoblood].
    Sheĭko EA; Shikhliarova AI
    Vopr Onkol; 2011; 57(4):493-6. PubMed ID: 22191240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.